Use of Elranatamab in Patients With High-risk Smoldering Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
Clinical Trials Related to Elranatamab
Related studies linked through entity extraction aliases.
MagnetisMM-32: A Study to Learn About the Study Medicine Called Elranatamab in People With Multiple Myeloma (MM) That Has Come Back After Taking Other Treatments (Including Prior Treatment With an Anti-CD38 Antibody and Lenalidomide)
- Status
- RECRUITING
- Phase
- PHASE3
Elranatamab in R/R Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Evaluate the Safety, Effectiveness and Tolerable Dose of Arlocabtagene Autoleucel (BMS-986393) in Novel Combinations in Participants With Relapsed and/or Refractory Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1
AZD0305 as Monotherapy or in Combination With Anticancer Agents in Participants With Multiple Myeloma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Elranatamab Post Trial Access Study for Participants With Multiple Myeloma (MM)
- Status
- RECRUITING
- Phase
- PHASE4
Self-administration of Subcutaneous Elranatamab in the Patients' Homes.
- Status
- RECRUITING
- Phase
- PHASE2
A Study to Learn About the Effectiveness of the Medicine Called Elranatamab in People With Relapsed Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
A Study Evaluating the Safety, Pharmacokinetics, and Activity of the Combination of Cevostamab and Elranatamab in Participants With Relapsed or Refractory Multiple Myeloma (R/R MM)
- Status
- RECRUITING
- Phase
- PHASE1
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
A Study to Learn About the Effects of the Combination of Elranatamab, Daratumumab and Lenalidomide Compared With Daratumumab, Bortezomib, Lenalidomide, and Dexamethasone in Patients With Newly Diagnosed Multiple Myeloma Who Are Not Candidates for Transplant
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Learn About the Medicine (Called Elranatamab) in People With Relapsed Refractory Multiple Myeloma
- Status
- COMPLETED
- Phase
- N/A
Study With Elranatamab Versus Lenalidomide in Patients With Newly Diagnosed Multiple Myeloma After Transplant
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Pre-approval Single-patient Expanded Access for Elranatamab (PF-06863135)
- Status
- NO_LONGER_AVAILABLE
- Phase
- N/A
A Study of Elranatamab (PF-06863135) in Chinese Participants With Refractory Multiple Myeloma.
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Learn About the Study Medicine Elranatamab Alone and With Daratumumab in People With Multiple Myeloma Who Have Received Other Treatments
- Status
- RECRUITING
- Phase
- PHASE3
A Study to Learn About the Study Medicine (Elranatamab) in Participants With Multiple Myeloma That Has Come Back After Responding to Treatment or Has Not Responded to Treatment
- Status
- COMPLETED
- Phase
- PHASE2
Study to Evaluate CCS1477 (Inobrodib) in Haematological Malignancies
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2